Core C: Molecualr Imaging High Throughput Screening Core (HTS)
核心 C:分子成像高通量筛选核心 (HTS)
基本信息
- 批准号:7287036
- 负责人:
- 金额:$ 18.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-28 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:ABCB1 geneBiological AssayBioluminescenceBlood CirculationCancer CenterCell Cycle RegulationCell DeathCellsCellular biologyChemistryCommunitiesCultured CellsDataEndopeptidasesEnzyme Inhibitor DrugsEnzyme InhibitorsFacility Construction Funding CategoryFundingGene ExpressionGenomeHousingHumanHuman ResourcesImageImage AnalysisInstitutesLibrariesLiquid substanceLuciferasesMedicalMolecularMolecular BankMolecular BiologyNotch Signaling PathwayPeptide HydrolasesPeptidesPharmaceutical PreparationsPharmacologyPhosphoric Monoester HydrolasesPhosphotransferasesProcessProtocols documentationRadiology SpecialtyRangeRegulationReporterResearch PersonnelResearch Project GrantsResource DevelopmentResourcesRobotRoboticsScienceScreening procedureSignal TransductionSiteSmall Interfering RNASpecialized CenterTNFRSF5 geneTherapeuticUnited States National Institutes of HealthUniversitiesWashingtonair filtercell growthcellular engineeringdayfallshigh throughput screeningin vivo Cellular and Molecular Imaging Centersinnovationinstrumentknock-downmedical schoolsmolecular imagingnovelpressureprotein phosphatase inhibitor-2protein protein interactionresearch and developmentresearch studyresponsesmall moleculesmall molecule librariesubiquitin-protein ligase
项目摘要
A.3.iii. High Throughput Screening Core (HTS)
In response to the NIH Roadmap to Molecular Libraries and Imaging, we have fully established a
P50 High Throughput Core. The new Core represents a multi-departmental effort with fiscal support for
establishing the Core coming from P50 funds in combination with the Departments of Radiology, Molecular
Biology & Pharmacology, and Cell Biology as well as the Howard Hughes Medical Institute. The Dean of
Washington University School of Medicine as well as the Director of the Washington University Siteman
Cancer Center joined our effort with the commitment of additional funds for further development of the
resource. This Core serves as an outstanding on-going example of how our P50 program has
leveraged university resources and continues to stimulate interdisciplinary molecular imaging
activity throughout the WU campus. We have optimized several robotic protocols and logistical
requirements for our first projects in high throughput screening and exciting data are now coming on-line
during the summer of 2006. The Core allows for automated screening of cells cultured in 96 or 384 plate
formants and can be applied to multiple investigator-initiated molecular imaging applications throughout the
university community. The applications include:
1) small molecule screens applied to cells engineered by WU investigators for imaging and
therapeutic drug leads.
2) small molecule or peptide screens to identify enzyme inhibitors (directed against high priority
proteases, kinases, phosphatases, etc.), or modulators of protein-protein interactions.
3) genome-wide siRNA library screens against kinases, phosphatases and E3-ligases in human
cells targeting signal transduction, cell growth or cell death responses.
Our first projects are focused on use of the novel split luciferase complementation imaging platform
developed in the Molecular Reporter Core for analysis of protein-protein interactions using siRNA libraries
against all known expressed human kinases and phosphatases. Knock-down strategies are also being
used to explore fusion reporters for bioluminescence readouts of cell cycle regulation, the Notch signaling
pathway, and regulation of MDR1 gene expression and other related discovery projects. We will soon be
incorporating small molecule libraries from the Chemistry Core. These directly demonstrate the cycle of
synergies between the Molecular Reporter Core, the Chemistry Core, the HTS Core and ICMIC R&D
Projects.
A.3.iii.高通量筛选核心 (HTS)
为了响应 NIH 分子库和成像路线图,我们已经全面建立了
P50 高吞吐量核心。新的核心代表了多部门的努力和财政支持
与放射科、分子科联合建立来自 P50 基金的核心
生物学与药理学、细胞生物学以及霍华德休斯医学研究所。院长
华盛顿大学医学院以及华盛顿大学西特曼院长
癌症中心加入了我们的努力,并承诺提供额外资金以进一步发展
资源。该核心是我们的 P50 计划如何实现的一个杰出的持续示例
发挥大学资源,持续激发跨学科分子影像
整个 WU 校园的活动。我们优化了多个机器人协议和物流
我们第一个高通量筛选项目的要求和令人兴奋的数据现已上线
2006 年夏季。Core 可以自动筛选在 96 或 384 平板中培养的细胞
共振峰,可应用于多个研究者发起的分子成像应用
大学社区。这些应用包括:
1) 小分子筛选应用于 WU 研究人员设计的细胞,用于成像和
治疗药物先导。
2) 小分子或肽筛选以鉴定酶抑制剂(针对高优先级
蛋白酶、激酶、磷酸酶等)或蛋白质-蛋白质相互作用的调节剂。
3) 针对人类激酶、磷酸酶和 E3 连接酶的全基因组 siRNA 文库筛选
细胞靶向信号转导、细胞生长或细胞死亡反应。
我们的第一个项目重点是使用新型分裂荧光素酶互补成像平台
在分子报告核心中开发,用于使用 siRNA 文库分析蛋白质-蛋白质相互作用
对抗所有已知表达的人类激酶和磷酸酶。击倒策略也正在实施
用于探索细胞周期调节生物发光读数的融合报告基因,Notch 信号传导
途径、MDR1 基因表达调控等相关发现项目。我们很快就会
合并来自化学核心的小分子库。这些直接体现了循环
分子报告核心、化学核心、HTS 核心和 ICMIC 研发之间的协同作用
项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HELEN M PIWNICA-WORMS其他文献
HELEN M PIWNICA-WORMS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HELEN M PIWNICA-WORMS', 18)}}的其他基金
Mechanisms of fasting-induced radioprotection of small intestinal epithelial cells
禁食诱导的小肠上皮细胞辐射防护机制
- 批准号:
10645872 - 财政年份:2023
- 资助金额:
$ 18.79万 - 项目类别:
Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation
禁食可保护小肠干细胞免受致命性 DNA 损伤:机制洞察和临床前转化
- 批准号:
10090461 - 财政年份:2017
- 资助金额:
$ 18.79万 - 项目类别:
Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation
禁食可保护小肠干细胞免受致命性 DNA 损伤:机制洞察和临床前转化
- 批准号:
9307224 - 财政年份:2017
- 资助金额:
$ 18.79万 - 项目类别:
CHARACTERIZATION OF PROTEIN PHOSPHORYLATION OF HUMAN CHK2 PROTEIN KINASE
人 CHK2 蛋白激酶的蛋白磷酸化特征
- 批准号:
8361353 - 财政年份:2011
- 资助金额:
$ 18.79万 - 项目类别:
CHARACTERIZATION OF PROTEIN PHOSPHORYLATION OF HUMAN CHK2 PROTEIN KINASE
人 CHK2 蛋白激酶的蛋白磷酸化特征
- 批准号:
8168703 - 财政年份:2010
- 资助金额:
$ 18.79万 - 项目类别:
CHARACTERIZATION OF PROTEIN PHOSPHORYLATION OF HUMAN CHK2 PROTEIN KINASE
人 CHK2 蛋白激酶的蛋白磷酸化特征
- 批准号:
7953916 - 财政年份:2009
- 资助金额:
$ 18.79万 - 项目类别:
CHARACTERIZATION OF PROTEIN PHOSPHORYLATION OF HUMAN CHK2 PROTEIN KINASE
人 CHK2 蛋白激酶的蛋白磷酸化特征
- 批准号:
7721480 - 财政年份:2008
- 资助金额:
$ 18.79万 - 项目类别:
Res Proj 2: Molecular Imaging Strategies to Study Cdc25A Regulation in vivo
Res Proj 2:研究 Cdc25A 体内调节的分子成像策略
- 批准号:
7287031 - 财政年份:2007
- 资助金额:
$ 18.79万 - 项目类别:
CHARACTERIZATION OF PROTEIN PHOSPHORYLATION OF HUMAN CHK2 PROTEIN KINASE
人 CHK2 蛋白激酶的蛋白磷酸化特征
- 批准号:
7355307 - 财政年份:2006
- 资助金额:
$ 18.79万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 18.79万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 18.79万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 18.79万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 18.79万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 18.79万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 18.79万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 18.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 18.79万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 18.79万 - 项目类别:
Postdoctoral Fellowships














{{item.name}}会员




